IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF- independent Smad signaling
Y Liu, Christoph Meyer, A. J. Mueller, Frank Herweck, Q Li, Ralf M. Muellenbach, PR Mertens, Steven Dooley, H Weng
Abstract
Y Liu, Christoph Meyer, A. J. Mueller, Frank Herweck, Q Li, Ralf M. Muellenbach, PR Mertens, Steven Dooley, H Weng
Abstract
Aims: Connective tissue growth factor (CTGF) plays a central role in stimulating extracellular matrix deposition in the liver, and hence is considered as a critical mediator of TGF-β dependent fibrogenesis. Hepatic stellate cells (HSCs) are known as the major source of CTGF. However, previous studies revealed that IL-13, rather than TGF-beta, represents the main inducer of CTGF expression in HSCs. Methods: We evaluate the effect of IL-13 on CTGF expression in primary cultured HSCs. We also investigated how IL-13 downstream signaling modulates CTGF expression in HSCs. Results: IL-13 induces a time- and dosage-dependent increase of CTGF in a TGF-beta independent manner. This process involves different Smad proteins and their upstream receptor kinases (ALKs). Smad1 and Smad2 were identified as key mediators for IL-13 dependent CTGF expression. Furthermore, IL-13 induces Stat6 phosphorylation in HSCs, but Stat6 was not involved in CTGF induction. Instead, the Erk1/2-MAPK pathway was responsible for IL-13 induced early Smad phosphorylation and CTGF production. Conclusion: We demonstrate that IL-13 induces CTGF expression in HSCs by activating TGF-beta independent ALK/Smad signaling via the Erk-MAPK pathway rather than via its canonical JAK/Stat6 pathway. These results may provide an improved new insight into the molecular mechanisms of pro-fibrotic IL-13 activity in the liver. Liver fibrosis - ALK - Stat6 - phosphor-Erk
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aims: Connective tissue growth factor (CTGF) plays a central role in stimulating extracellular matrix deposition in the liver, and hence is considered as a critical mediator of TGF-β dependent fibrogenesis. Hepatic stellate cells (HSCs) are known as the major source of CTGF. However, previous studies revealed that IL-13, rather than TGF-beta, represents the main inducer of CTGF expression in HSCs. Methods: We evaluate the effect of IL-13 on CTGF expression in primary cultured HSCs. We also investigated how IL-13 downstream signaling modulates CTGF expression in HSCs. Results: IL-13 induces a time- and dosage-dependent increase of CTGF in a TGF-beta independent manner. This process involves different Smad proteins and their upstream receptor kinases (ALKs). Smad1 and Smad2 were identified as key mediators for IL-13 dependent CTGF expression. Furthermore, IL-13 induces Stat6 phosphorylation in HSCs, but Stat6 was not involved in CTGF induction. Instead, the Erk1/2-MAPK pathway was responsible for IL-13 induced early Smad phosphorylation and CTGF production. Conclusion: We demonstrate that IL-13 induces CTGF expression in HSCs by activating TGF-beta independent ALK/Smad signaling via the Erk-MAPK pathway rather than via its canonical JAK/Stat6 pathway. These results may provide an improved new insight into the molecular mechanisms of pro-fibrotic IL-13 activity in the liver. Liver fibrosis - ALK - Stat6 - phosphor-Erk
Key concepts: CTGF, SMAD, Hepatic stellate cell, Cell biology, Growth factor, MAPK/ERK pathway, Signal transduction, Biology